SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0269881106059692v1
20/5/629    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Li, Y.-F.
Right arrow Articles by Luo, Z.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y.-F.
Right arrow Articles by Luo, Z.-P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Inhibition of N-methyl-D-aspartate receptor function appears to be one of the common actions for antidepressants

Yun-Feng Li

You-Zhi Zhang

Yan-Qin Liu

Division of Psychopharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing, China

Heng-Lin Wang

Department of Anesthesiology, 309 Hospital of Beijing, China

Jiang-Bei Cao

Ting-Ting Guan

Zhi-Pu Luo

Division of Psychopharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing, China

In order to explore the possible common action mechanisms of three kinds of classical antidepressants, inhibition of drugs on the N-methyl-D-aspartate (NMDA)–Ca2–nitric oxide synthase (NOS) signal pathway was observed. With 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay and lactic dehydrogenase (LDH) assay, classical antidepressants, desipramine (1, 10 M), fluoxetine (0.625–10 M) or moclobemide (2.5, 10 M) antagonized NMDA 300 M induced-lesion in PC12 cells. Using fura-2/AM (acetoxymethyl ester) labelling assay, desipramine or fluoxetine at doses 1, 5 M attenuated the intracellular Ca2 overload induced by NMDA 200 M for 24h in PC12 cells. Meanwhile, using confocal microscope, it was also found that desipramine 5 M, fluoxetine 2.5 M or moclobemide 10 M decreased the NMDA 20 M induced intracellular Ca2 overload in primarily cultured rat hippocampal neurons. Furthermore, desipramine (1, 5 M), fluoxetine (1, 5 M) or moclobemide (2.5, 10 M) significantly inhibited NOS activity in NMDA (300 M) treated PC12 cells for 4h. In summary, we suggest that inhibition on the function of NMDA–Ca2 –NOS signal pathway appears to be one of the common actions for antidepressants despite their remarkably different structures, which is expected to have great implication for the evaluation and screening in vitro of new antidepressants.

Key Words: antidepressants • PC12 cells • N-methyl-D-aspartate • Ca2 • nitric oxide synthase • hippocampal neurons

This version was published on September 1, 2006

Journal of Psychopharmacology, Vol. 20, No. 5, 629-635 (2006)
DOI: 10.1177/0269881106059692


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement